Physician
Molly Catherine Boyd-Smith, M.D.
According to 2025 Medicare claims, Molly Boyd-Smith, M.D. (NPI: 1114161213) practices medical toxicology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Albany, NY. This provider's primary affiliated billing organization is ALBANY MEDICAL COLLEGE (NPI: 1497921688; TIN: 141338310) and primary practice location at 12208-3478.
Boyd-Smith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 208 traditional Medicare patients, billed 246 HCPCS/CPT codes, and received $25,207 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 44 prescription claims across 20 beneficiaries totaling $6,799 in drug costs, led by Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $47,411 to $25,207. In contrast, Part D prescription costs have risen steadily, from $1,332 to $6,799. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.